Pathophysiological and genetic basis of osteoporosis;Physiopathologie et genetique de l'osteoporose

Annales de Medecine Interne

Volumn 151, Issue 5, 2000, Pages 373-379

  Cohen Solal, M ^a   Marie, P ^a   De Vernejoul, M C ^a  

^a CENTRE VIGGO PETERSEN   (France)

Author keywords

Osteoporosis

Indexed keywords

CYTOKINE; ESTROGEN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; ESTROGEN;

ENVIRONMENTAL FACTOR; ESTROGEN DEFICIENCY; HEREDITY; OSTEOBLAST; OSTEOPOROSIS; PATHOPHYSIOLOGY; REVIEW; BONE REMODELING; CELL DIFFERENTIATION; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; RISK FACTOR;

BONE REMODELING; CELL DIFFERENTIATION; CYTOKINES; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; OSTEOBLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033793727     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex
2. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
3. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
4. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
5. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor
6. CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation
7. Regulation of chondrocyte differentiation by Cbfa1
8. Maturational disturbance of chondrocytes in Cbfa1-deficient mice
9. Expression of core binding factor Osf2/Cbfa1 and bone sialoprotein in tooth development
10. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: Regulation of mRNA expression of osteoclast differentiation factor (ODF)
11. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes
12. Modulation of osteoclast differentiation
13. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
14. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
15. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
16. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
17. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both and mouse osteoclast formation in vitro
18. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
19. Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids
20. Transforming growth factor-betal increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells
21. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
22. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
23. Estrogen, cytokines, and pathogenesis of post menopausal osteoporosis
24. Bone marrow, cytokines and bone remodelling
25. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells
26. Osteoclasts from human giant cell tumors of bone lack estrogen receptors
27. Evidence of estrogen receptors in normal human osteoblast-like cells
28. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells
29. Cloning of a novel receptor expressed in rat prostate and ovary
30. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells
31. Expression of estrogen receptor beta in rat bone
32. Estrogen receptor-alpha is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression
33. Ovarian steroid treatment blocks a post-menopausal increase in blood monocyte interleukin 1 release
34. Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells
35. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice
36. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency
37. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
38. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
39. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines
40. Increased bone resorbing activity of peripheral monocyte culture supernatants in elderly women
41. Increased cytokine secretion by human bone marrow cells after menopause of discontinuation of estrogen replacement
42. Bone resorption at the femoral neck is dependent on local factors in non osteoporotic late postmenopausal women an in vitro-in vivo study
43. Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL1 and IL6
44. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone
45. Short-term local injections of transforming growth factor-β1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats
46. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β
47. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts
48. Concentration of transforming growth factor β in human bone tissue: Relationship to age, menopause, bone turnover and bone volume
49. Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: Lack of correlation with bone mass
50. Facteurs de croissance et formation osseuse dans les osteopenies: Roles de I'IGF-I et du TGF-β
51. Reduced bone mass in daughters of women with osteoporosis
52. Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heretability estimates
53. Bone mass in middle-aged osteoporotic men and relatives: Familial effect
54. Segregation analysis and variance components analysis of bone mineral density in healthy families
55. Environmental and genetic factors affecting bone mass
56. Prediction of bone density from vitamin D receptor alleles
57. Are vitamin D receptor polymorphisms associated with bone mineral density. A meta-analysis
58. Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
59. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis